SAB Biotherapeutics (SABS) Stock Price & Financial Analysis
SAB Biotherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About SAB Biotherapeutics
What is the current stock price for SABS?
As of the latest trading session, SABS stock trades at $3.55. The 52-week range is $1.60–$6.60, with a day range of $3.40–$3.60.
What is the P/E ratio for SABS?
SAB Biotherapeutics's trailing P/E ratio is 17.1, meaning investors pay $17.1 for every $1 of annual earnings. SAB Biotherapeutics operates in the Healthcare sector.
Does SABS pay dividends?
SAB Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for SABS?
Based on 2 analysts, the consensus for SABS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of SABS?
SAB Biotherapeutics's market capitalization is $217.8M, classifying it as a micro-cap company. SAB Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.